Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 18,397	$ 16,557
Accounts receivable, net	11,596	13,973
Inventory	7,738	6,493
Prepaid expenses and other current assets	2,288	2,921
Total current assets	40,019	39,944
Property and equipment, net	284	377
Right of use assets, net	581	937
Intangible assets, net	2,209	2,210
Other assets	733	655
Total assets	43,826	44,123
Current liabilities:
Accounts payable	16,064	13,679
Accrued and other expenses	11,003	15,051
Current portion of deferred revenues	1,144	1,166
Line of credit	7,212	9,250
Current portion of long-term debt	4,032	5,944
Total current liabilities	39,455	45,090
Common stock warrant liabilities	25,457	27,781
Other long-term liabilities	705	928
Total liabilities	65,617	73,799
Commitments and Contingencies
Stockholders’ deficit:
Common stock, $0.0001 par value, 107,142,857 shares authorized as of March 31, 2024 and December 31, 2023; 9,014,403 and 8,797,456 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively.	1	1
Additional paid-in capital	219,450	218,127
Accumulated deficit	(252,385)	(255,659)
Total stockholders’ deficit	(32,934)	(37,531)
Total liabilities, convertible preferred stock, and stockholders’ deficit	43,826	44,123
Series A Convertible Preferred Stock
Current liabilities:
Series A convertible preferred stock, $0.0001 par value, 27,450 and 28,628 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	8,735	7,855
Series B Convertible Preferred Stock
Current liabilities:
Series A convertible preferred stock, $0.0001 par value, 27,450 and 28,628 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	$ 2,408	$ 0